SIRT7 and pancreatic neoplasm: In sum, data suggest that SIRT7 may be a potential novel biomarker for prognosis in pancreatic cancer (83), a circulating marker in head and neck squamous cell carcinoma (73), and a predictive biomarker of pancreatic cancer (PCa) aggressiveness (91).